In this issue:
Dramatically improved survival from AML in Australia
Lymphoma/leukaemia Clinical Practice Guidelines
TGA
New registrations
Medicines under evaluation
AusPARs
PBS listings
Upcoming PBAC agendas
Recent FDA approvals
UK to subsidise blinatumomab for MRD-negative B-ALL
FDA scraps animal testing in preclinical safety studies
The Leukaemia Foundation merges with Bloomhill Cancer Care
Trial of first-in-class myeloid engager immunotherapy
The Medscape myelofibrosis podcast
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)